Patent application number | Description | Published |
20080318973 | Urotensin II receptor antagonists - This invention is directed to a compound of Formula (I): | 12-25-2008 |
20090068246 | COLLAGEN-RELATED PEPTIDES AND USES THEREOF - The present invention relates to a collagen-related polypeptide (CRP) having hydrophobic amino acid groups at the N- and C-termini capable of non-covalent self-assembly into collagen mimetic triple helices and fibrils thereof and the synthesis, methods of use and compositions thereof. | 03-12-2009 |
20090124804 | Enantioselective process for preparing a substituted alkanoic acid - The present invention is directed to a process for enantioselectively preparing substituted piperidine alkanoic acid integrin antagonist compounds. | 05-14-2009 |
20090299034 | Collagen-related peptides - The present invention relates to a collagen-related polypeptide (CRP) having hydrophobic amino acid groups at the N- and C-termini capable of non-covalent self-assembly into collagen mimetic triple helices and fibrils thereof and the synthesis, methods of use and compositions thereof. | 12-03-2009 |
20100029616 | UROTENSIN II RECEPTOR ANTAGONISTS - The present invention is directed to compounds of formula (I) | 02-04-2010 |
20110136824 | UROTENSIN II RECEPTOR ANTAGONISTS - The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described. | 06-09-2011 |
20110269768 | UROTENSIN II RECEPTOR ANTAGONISTS - This invention is directed to a compound of Formula (I): | 11-03-2011 |
20120214817 | UROTENSIN II RECEPTOR ANTAGONISTS - The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described. | 08-23-2012 |